Molecules Engineered Against Oncogenic Proteins and Cancer: Discovery, Design, and Development - Image 1

Price loading...

Wiley Molecules Engineered Against Oncogenic Proteins and Cancer: Discovery, Design, and Development

Name: Molecules Engineered Against Oncogenic Proteins and Cancer: Discovery, Design, and Development
Brand: Wiley

Oncology

Price History & Forecast

No Price Data Available

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Description

Molecules Engineered Against Oncogenic Proteins and Cancer A comprehensive review of the latest molecular advances in cancer treatment Featuring 91 total small molecule kinase/KRAS inhibitors, 80 of which are FDA-approved, Molecules Engineered Against Oncogenic Proteins and Cancer documents the recent scientific advances that have transformed one of medicine’s most challenging areas―cancer treatment. Most of these inhibitors specifically block oncogene-induced carcinogenic proteins with results that have dramatically advanced the treatment of cancer. In addition, the structural formulas of more than 100 kinase/KRAS inhibitors in clinical trials are presented. With a very well-known chemist as an author, Molecules Engineered Against Oncogenic Proteins and Cancer includes information on: Each molecule’s structure, function of the kinase target and relevance to cancer, the drug discovery process, and molecular details of drug action Mutated protein kinases as oncoproteins and targets for inhibition, along with the details of discovery for each antitumor antikinase agent History of oncoprotein inhibitors and their role in advancing the treatment and understanding of cancer The discovery process as a whole, effective strategies for innovation, ongoing challenges, and a glimpse of the future of the field Combining the most significant recent discoveries in a unique and useful way, Molecules Engineered Against Oncogenic Proteins and Cancer is an essential resource for researchers and students in bioscience, medicine, chemistry, and oncology as well as for those at industrial companies involved in therapeutic discovery.

Product Specifications

Brand: Wiley
Format: hardcover
ASIN: 1394207085
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Oncology
Domain: Amazon UK
Release Date: 09 August 2023
Listed Since: 07 March 2023

Barcode

No barcode data available

Wiley Molecules Engineered Against Oncogenic Proteins and Cancer: Discovery, Design, and Development

Price History & Forecast

No Price Data Available

Price Distribution

Description

Product Specifications

Barcode

Similar Products You Might Like

Chemistry and Pharmacology of Anticancer Drugs

CRC Press - Chemistry and Pharmacology of Anticancer Drugs

Cancer Drug Design and Discovery

Wiley Anticancer Therapeutics - Oncology Drug Design Book

Cancer Therapeutics: Experimental and Clinical Agents (Cancer Drug Discovery and Development)

Cancer Chemotherapy: Basic Science to the Clinic

Macromolecular Anticancer Therapeutics (Cancer Drug Discovery and Development)

Macromolecular Anticancer Therapeutics (Cancer Drug Discovery and Development)

Medicines for Cancer: Mechanism of Action and Clinical Pharmacology of Chemo, Hormonal, Targeted, and Immunotherapies

Anticancer Drug Development

Medicinal Chemistry of Anticancer Drugs

Small Molecules in Oncology: 184 (Recent Results in Cancer Research, 184)

Small Molecules for Cancer Treatment

Small Molecules in Oncology: 211 (Recent Results in Cancer Research, 211)

Small Molecules in Oncology: 211 (Recent Results in Cancer Research, 211)

Next Generation Kinase Inhibitors: Moving Beyond the ATP Binding/Catalytic Sites

Academic Press Protein Kinase Inhibitors: Discovery to Therapeutics

Protein Tyrosine Kinases: From Inhibitors to Useful Drugs (Cancer Drug Discovery and Development)

Cancer Drug Resistance (Cancer Drug Discovery and Development)

Medicinal Chemistry of Anticancer Drugs

Small Molecules in Oncology: 201 (Recent Results in Cancer Research)

Medicinal Chemistry of Anticancer Drugs

Kinase Inhibitor Drugs (Wiley Series in Drug Discovery and Development)

Apoptosis and Cancer Chemotherapy (Cancer Drug Discovery and Development)